Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
- 16 August 2024
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (11) , e31286
Abstract
This retrospective study at the University of Texas MD Anderson Cancer Center evaluated frontline venetoclax combination therapy in 11 pediatric/adolescent patients with acute myeloid leukemia (AML). Despite the small sample size and retrospective nature, the treatment demonstrated safety and potential efficacy, with most patients achieving early complete remission. Adverse events were consistent with other AML therapies, and no discontinuations due to toxicity occurred. While acknowledging study limitations, including selection bias and diverse concurrent therapies, this research underscores the promising role of venetoclax in pediatric AML. Further investigation is crucial to validate its long‐term efficacy in this population.Keywords
This publication has 20 references indexed in Scilit:
- Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2023
- Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomesLeukemia & Lymphoma, 2022
- Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndromeCancer Science, 2021
- How I treat pediatric acute myeloid leukemiaBlood, 2021
- Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four CoursesJournal of Clinical Oncology, 2021
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaNew England Journal of Medicine, 2020
- Single‐center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemiaPediatric Blood & Cancer, 2020
- Venetoclax for AML: changing the treatment paradigmBlood Advances, 2019
- Acute myelogenous leukemia in adolescents and young adultsPediatric Blood & Cancer, 2018
- The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactionsNature Medicine, 2017